MPI and TD2 join in strategic collaboration to provide drug

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
MPI and TD2 join in strategic collaboration to provide drug developers a unique Multi Biomarker direct path to drug approval
  • MPI's Drug Response Predictor (DRP) can generate new and unique clinically relevant gene signatures - a strong complementary drug development tool
  • TD2 is an oncology drug development company that customizes clinical trial design and execution for its customers by applying rigorous and high-throughput translational preclinical development, with best in class regulatory and clinical expertise.

HOERSHOLM, Denmark and SCOTTSDALE, Ariz., April 3, 2014 (GLOBE NEWSWIRE) -- Medical Prognosis Institute A/S (MPI) - a Danish company and Translational Drug Development LLC (TD2) based in Scottsdale, Arizona, today announced a strategic collaboration offering a proprietary service that defines which initial clinical indication would most likely lead to drug approval. "This technology can dramatically increase the probability of early clinical success" said Dr. Stephen Gately, CEO for TD2.

The use of these data is supported by strategic counselling from highly experienced translational experts focused on rapid approval. "The collaboration with TD2 is a fantastic opportunity for MPI to integrate our technology in the highly professional TD2 team" said Peter Buhl Jensen, CEO for MPI.

" I believe there is great synergy between MPI and TD2 services. These companies share the goal of providing data and clinically relevant insight to the global pharmaceutical and biotech industries as well as leading academic institutions, to accelerate oncology drug development" said Dr. Daniel Von Hoff, Chief Development Officer for TD2.

About MPI:

MPI was founded to improve the efficacy of cancer drugs through its Multi Biomarker technology called Drug Response Predictor (DRP). DRP is a validated, unique Multi Biomarker built on an algorithm from Big Data derived from human cancer tissue. DRP can be added to and will strengthen existing tools already being used in the drug development field.

MPI has incorporated in Arizona (MPI Inc.) and will establish a laboratory in the TD2 facilities to execute on joint collaborations in a capital efficient manner.

About TD2:

TD2 is an oncology drug development company that has facilities for the preclinical and clinical testing of candidate cancer drugs and treatments, as well as expertise in regulatory affairs. For preclinical studies, TD2 has more than 200 established models of human cancer. TD2 has performed early-mid phase clinical studies on over 400 new anticancer agents and has worked with more than 350 biotech and pharmaceutical companies worldwide. TD2 has an unmatched access to patients for clinical trials.

For further information please contact

TD2:

Stephen Gately, CEO
email: sgately@td2inc.com
+1 602-358-8300
MPI:

Peter Buhl Jensen, CEO
e-mail: pbj@medical-prognosis.com
Mobil: +45 21 60 89 22

Certified Advisor to MPI: Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen 44, 2900 Hellerup, Denmark

MPI and TD2 join in strategic collaboration http://hugin.info/158657/R/1774111/604764.pdf

HUG#1774111

Scroll down for more posts ▼

Top 10 Most Recent News Articles

James Hardie Joins S&P MidCap 400; Roku Acquired

Updated Category News Views 117

A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 132

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
BlackLine's SAP Woes Spark Investor Scrutiny

Updated Category News Views 94

What Triggered This Investigation? Here we go again, folks. BlackLine's taking a hit, and it ain't pretty. They're reeling from a whopping 17.4% drop in their share price after cutting their fiscal 2026 outlook. You can bet the folks with stakes in BlackLine (NASDAQ:BL) are feeling the burn. This all comes down to a mess involving their SAP SolEx channel. Let's dive into...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 117

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 101

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 116

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 77

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 168

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 167

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Sensitron's 270VDC SSPCs: A Power System Shake-Up

Updated Category News Views 196

Revolutionizing Power Distribution with Sensitron Some days, the tech world dishes out real game-changers, and looks like November 6, 2026, was one of those days. Sensitron Semiconductor dropped a bombshell with their SPHM/SEHM Series—a brand-new lineup of programmable 16-channel Solid State Power Controllers (SSPCs). Tailored for the grueling demands of 270VDC power...

Continue Reading

Top 5 Most Recently Viewed Articles

Race Communications Expands 10G Fiber Internet to New Areas

Updated Category News Views 128

Race Communications Expands Access to High-Speed Fiber Internet Today, Race Communications, a prominent internet service provider in California, is thrilled to announce its expansion into four new communities. The cities of Merced, Turlock, Porterville, and Atwater are set to benefit from Race's state-of-the-art fiber-optic network. This new initiative aims to bring...

Continue Reading
Leopard PROWESS: Transforming Corporate Counsel Solutions

Updated Category News Views 73

Introducing Leopard PROWESS for Legal Counsel Selection Leopard PROWESS: Panel Ranking and Organizational Workflow for Enhanced Selection System Leopard Solutions, a prominent legal data and analytics provider, has launched an innovative platform called Leopard PROWESS. This revolutionary system dramatically enhances the selection process of outside counsel for corporate...

Continue Reading
Opus Technologies Introduces Paysemble™ for Payment Solutions

Updated Category News Views 137

Opus Technologies Introduces Paysemble™ for Streamlined Payment Integration Opus Technologies is leading the charge in the payments sector with its innovative solution, Paysemble™. This powerful tool is crafted to simplify payment integrations, making communication smoother and boosting payment security through advanced technology. A Holistic Approach to Payment...

Continue Reading
Navigating Healthcare Uncertainty with a Technology-First Strategy

Updated Category News Views 170

Embracing a Technology-First Action Plan in Healthcare The ever-evolving landscape of healthcare presents unique challenges for organizations, including regulatory changes, escalating clinical costs, and workforce shortages. Amidst these increasing hurdles, many healthcare leaders find themselves in a reactive stance, rather than anticipating future changes. A recent...

Continue Reading
SIMONA AMERICA Group Makes Strides with Sustainability Goals

Updated Category News Views 316

Commitment to Sustainability by SIMONA AMERICA Group SIMONA AMERICA Group is making impressive advancements in its sustainability efforts, having received validation from the Science Based Targets initiative (SBTi) for its greenhouse gas (GHG) reduction targets. This validation highlights the company's serious dedication to minimizing its environmental impact while...

Continue Reading